US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.540
  • -0.080-0.59%
Close Feb 14 16:00 ET
  • 13.540
  • 0.0000.00%
Post 20:01 ET
42.93BMarket Cap31.56P/E (TTM)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Total revenue
2.96%1.14T
12.75%1.18T
14.11%1.21T
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
Operating revenue
2.96%1.14T
12.75%1.18T
14.11%1.21T
5.87%4.26T
9.91%1.05T
1.33%1.11T
4.07%1.04T
8.86%1.06T
12.85%4.03T
9.49%956.16B
Cost of revenue
9.85%416.87B
14.76%394.31B
20.50%386.95B
14.68%1.43T
23.48%382.5B
12.95%379.48B
12.49%343.58B
9.64%321.11B
12.40%1.24T
0.45%309.77B
Gross profit
-0.61%727.25B
11.75%781.73B
11.33%821.04B
1.93%2.84T
3.40%668.37B
-3.80%731.71B
0.38%699.51B
8.52%737.5B
13.05%2.78T
14.42%646.38B
Operating expense
-5.44%749.7B
-32.15%508.09B
15.08%654.71B
12.91%2.52T
15.83%571.56B
29.21%792.79B
26.40%748.85B
7.54%568.93B
16.30%2.23T
2.52%493.44B
Selling and administrative expenses
1.15%270.59B
6.06%268.28B
8.83%270.03B
5.67%1.05T
11.95%285.23B
1.99%267.52B
1.70%252.95B
7.19%248.11B
12.52%997.31B
14.04%254.8B
Research and development costs
-9.17%170.19B
-4.56%175.56B
3.52%168.46B
15.25%729.92B
21.69%195.86B
7.30%187.38B
19.33%183.95B
13.32%162.74B
20.38%633.33B
12.06%160.94B
Depreciation amortization depletion
-35.72%162.68B
-52.28%114.65B
25.81%162.83B
20.22%652.12B
8.92%145.11B
86.68%253.09B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
-Depreciation and amortization
-35.72%162.68B
-52.28%114.65B
25.81%162.83B
20.22%652.12B
8.92%145.11B
86.68%253.09B
68.75%240.24B
-1.41%129.42B
14.70%542.44B
-10.76%133.22B
Other operating expenses
72.46%146.24B
-170.30%-50.41B
86.29%53.38B
44.78%80.27B
1.58%-54.65B
106.40%84.8B
51.99%71.71B
26.22%28.66B
80.28%55.44B
-58.59%-55.53B
Operating profit
63.25%-22.45B
654.57%273.64B
-1.33%166.33B
-42.16%320.95B
-36.70%96.81B
-141.56%-61.08B
-147.25%-49.34B
12.00%168.57B
1.62%554.89B
82.99%152.95B
Net non-operating interest income expense
13.83%-38.58B
-32.21%-64.34B
12.40%-29.01B
-13.84%-140.46B
73.14%-13.9B
-17.62%-44.78B
-24.71%-48.66B
-707.04%-33.12B
0.07%-123.39B
-126.11%-51.75B
Non-operating interest income
-132.07%-6.99B
-56.02%4.12B
15.96%30.68B
105.03%11.29B
29.85%-34.81B
-47.72%21.79B
-36.69%9.36B
-56.58%26.46B
19.97%5.51B
-29.37%-49.62B
Non-operating interest expense
-52.54%31.6B
17.98%68.45B
0.19%59.69B
2.19%119.54B
-442.57%-53.13B
-16.53%66.57B
7.84%58.02B
7.40%59.58B
-4.46%116.97B
53.61%-9.79B
Total other finance cost
----
----
----
170.31%32.22B
----
----
----
----
111.50%11.92B
----
Other net income (expense)
-47.68%87.44B
-4,540.79%-89.93B
-70.33%-712M
-126.37%-127.7B
-144.81%-130.43B
9,557.89%167.12B
333.03%2.03B
15.90%-418M
52.99%-56.41B
53.57%-53.28B
Gain on sale of security
----
----
----
-241.82%-9.13B
----
----
----
----
126.60%6.44B
----
Earnings from equity interest
-273.67%-1.95B
-126.42%-535M
-70.33%-712M
-53.05%6.47B
-77.88%3.74B
163.61%1.12B
333.03%2.03B
15.90%-418M
300.23%13.79B
1,137.98%16.92B
Special income (charges)
----
----
----
-63.15%-125.04B
----
----
----
----
13.79%-76.64B
----
-Less：Restructuring and merger&acquisition
----
----
----
61.51%102.12B
----
----
----
----
-12.96%63.23B
----
-Less:Other special charges
----
----
----
122.71%18.16B
----
----
----
----
120.50%8.15B
----
-Write off
----
----
----
-10.04%12.74B
----
----
----
----
-31.67%14.16B
----
-Gain on sale of business
----
----
----
15.04%7.83B
----
----
----
----
-2.98%6.81B
----
-Gain on sale of property,plant,equipment
----
----
----
-93.12%144M
----
----
----
----
82.40%2.09B
----
Income before tax
-56.89%26.41B
224.37%119.37B
1.16%136.6B
-85.93%52.79B
-199.18%-47.52B
-42.83%61.26B
-248.69%-95.98B
-13.15%135.03B
23.97%375.09B
188.65%47.92B
Income tax
105.78%2.57B
156.79%27.27B
-9.47%41.3B
-257.46%-91.41B
-365.38%-44.53B
-270.92%-44.5B
-1,804.26%-48.01B
-9.56%45.63B
-19.82%58.05B
139.32%16.78B
Net income
-77.46%23.84B
292.01%92.11B
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.71%31.14B
Net income continuous Operations
-77.46%23.84B
292.00%92.11B
6.59%95.3B
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.72%31.14B
Minority interest income
31.43%46M
3.39%61M
363.64%51M
519.05%130M
1,100.00%24M
59.09%35M
690.00%59M
57.14%11M
-80.37%21M
111.76%2M
Net income attributable to the parent company
-77.50%23.79B
291.64%92.05B
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-77.50%23.79B
291.64%92.05B
6.55%95.25B
-54.56%144.07B
-109.69%-3.02B
-11.25%105.72B
-177.79%-48.03B
-14.87%89.4B
37.80%317.02B
374.12%31.13B
Basic earnings per share
-78.01%7.43
289.50%29.07
5.56%30.355
-54.92%46.045
-110.07%-1.005
-11.80%33.795
-177.14%-15.34
-15.35%28.755
38.84%102.145
387.34%9.985
Diluted earnings per share
-78.20%7.29
286.34%28.585
4.94%29.97
-54.86%45.58
-110.42%-1.005
-11.84%33.44
-177.71%-15.34
-15.45%28.56
38.44%100.97
369.41%9.645
Dividend per share
0
-2.29%46.5694
0
3.35%91.889
7.08%44.2266
0
0.11%47.6624
0
4.95%88.9091
2.53%41.301
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Total revenue 2.96%1.14T12.75%1.18T14.11%1.21T5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B
Operating revenue 2.96%1.14T12.75%1.18T14.11%1.21T5.87%4.26T9.91%1.05T1.33%1.11T4.07%1.04T8.86%1.06T12.85%4.03T9.49%956.16B
Cost of revenue 9.85%416.87B14.76%394.31B20.50%386.95B14.68%1.43T23.48%382.5B12.95%379.48B12.49%343.58B9.64%321.11B12.40%1.24T0.45%309.77B
Gross profit -0.61%727.25B11.75%781.73B11.33%821.04B1.93%2.84T3.40%668.37B-3.80%731.71B0.38%699.51B8.52%737.5B13.05%2.78T14.42%646.38B
Operating expense -5.44%749.7B-32.15%508.09B15.08%654.71B12.91%2.52T15.83%571.56B29.21%792.79B26.40%748.85B7.54%568.93B16.30%2.23T2.52%493.44B
Selling and administrative expenses 1.15%270.59B6.06%268.28B8.83%270.03B5.67%1.05T11.95%285.23B1.99%267.52B1.70%252.95B7.19%248.11B12.52%997.31B14.04%254.8B
Research and development costs -9.17%170.19B-4.56%175.56B3.52%168.46B15.25%729.92B21.69%195.86B7.30%187.38B19.33%183.95B13.32%162.74B20.38%633.33B12.06%160.94B
Depreciation amortization depletion -35.72%162.68B-52.28%114.65B25.81%162.83B20.22%652.12B8.92%145.11B86.68%253.09B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B
-Depreciation and amortization -35.72%162.68B-52.28%114.65B25.81%162.83B20.22%652.12B8.92%145.11B86.68%253.09B68.75%240.24B-1.41%129.42B14.70%542.44B-10.76%133.22B
Other operating expenses 72.46%146.24B-170.30%-50.41B86.29%53.38B44.78%80.27B1.58%-54.65B106.40%84.8B51.99%71.71B26.22%28.66B80.28%55.44B-58.59%-55.53B
Operating profit 63.25%-22.45B654.57%273.64B-1.33%166.33B-42.16%320.95B-36.70%96.81B-141.56%-61.08B-147.25%-49.34B12.00%168.57B1.62%554.89B82.99%152.95B
Net non-operating interest income expense 13.83%-38.58B-32.21%-64.34B12.40%-29.01B-13.84%-140.46B73.14%-13.9B-17.62%-44.78B-24.71%-48.66B-707.04%-33.12B0.07%-123.39B-126.11%-51.75B
Non-operating interest income -132.07%-6.99B-56.02%4.12B15.96%30.68B105.03%11.29B29.85%-34.81B-47.72%21.79B-36.69%9.36B-56.58%26.46B19.97%5.51B-29.37%-49.62B
Non-operating interest expense -52.54%31.6B17.98%68.45B0.19%59.69B2.19%119.54B-442.57%-53.13B-16.53%66.57B7.84%58.02B7.40%59.58B-4.46%116.97B53.61%-9.79B
Total other finance cost ------------170.31%32.22B----------------111.50%11.92B----
Other net income (expense) -47.68%87.44B-4,540.79%-89.93B-70.33%-712M-126.37%-127.7B-144.81%-130.43B9,557.89%167.12B333.03%2.03B15.90%-418M52.99%-56.41B53.57%-53.28B
Gain on sale of security -------------241.82%-9.13B----------------126.60%6.44B----
Earnings from equity interest -273.67%-1.95B-126.42%-535M-70.33%-712M-53.05%6.47B-77.88%3.74B163.61%1.12B333.03%2.03B15.90%-418M300.23%13.79B1,137.98%16.92B
Special income (charges) -------------63.15%-125.04B----------------13.79%-76.64B----
-Less：Restructuring and merger&acquisition ------------61.51%102.12B-----------------12.96%63.23B----
-Less:Other special charges ------------122.71%18.16B----------------120.50%8.15B----
-Write off -------------10.04%12.74B-----------------31.67%14.16B----
-Gain on sale of business ------------15.04%7.83B-----------------2.98%6.81B----
-Gain on sale of property,plant,equipment -------------93.12%144M----------------82.40%2.09B----
Income before tax -56.89%26.41B224.37%119.37B1.16%136.6B-85.93%52.79B-199.18%-47.52B-42.83%61.26B-248.69%-95.98B-13.15%135.03B23.97%375.09B188.65%47.92B
Income tax 105.78%2.57B156.79%27.27B-9.47%41.3B-257.46%-91.41B-365.38%-44.53B-270.92%-44.5B-1,804.26%-48.01B-9.56%45.63B-19.82%58.05B139.32%16.78B
Net income -77.46%23.84B292.01%92.11B6.59%95.3B-54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.71%31.14B
Net income continuous Operations -77.46%23.84B292.00%92.11B6.59%95.3B-54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.72%31.14B
Minority interest income 31.43%46M3.39%61M363.64%51M519.05%130M1,100.00%24M59.09%35M690.00%59M57.14%11M-80.37%21M111.76%2M
Net income attributable to the parent company -77.50%23.79B291.64%92.05B6.55%95.25B-54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -77.50%23.79B291.64%92.05B6.55%95.25B-54.56%144.07B-109.69%-3.02B-11.25%105.72B-177.79%-48.03B-14.87%89.4B37.80%317.02B374.12%31.13B
Basic earnings per share -78.01%7.43289.50%29.075.56%30.355-54.92%46.045-110.07%-1.005-11.80%33.795-177.14%-15.34-15.35%28.75538.84%102.145387.34%9.985
Diluted earnings per share -78.20%7.29286.34%28.5854.94%29.97-54.86%45.58-110.42%-1.005-11.84%33.44-177.71%-15.34-15.45%28.5638.44%100.97369.41%9.645
Dividend per share 0-2.29%46.569403.35%91.8897.08%44.226600.11%47.662404.95%88.90912.53%41.301
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
Micron Technology
MU
+4.04%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.74%